2nd Quarter - Report
AVENUE SOLUTIONS for GENENTECH USA, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; H.R. 946/S. 1862, ORPHAN Cures Act; Issues related to Most Favored Nation (MFN) drug pricing proposal; H.R.4299, Protecting Patient Access to Cancer and Complex Therapies Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW FUENTES | — |
| TRACY SPICER | — |
Health Issues HCR
Issues related to 340b drug pricing program; Health care issues in H.R.1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21);
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW FUENTES | — |
| TRACY SPICER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.